Kevin Bloh, MS
B.S. Elizabethtown College
M.S. Drexel University College of Medicine
Kevin’s current research focus is utilizing various CRISPR gene editing systems to specifically target transformation-sufficient mutations in the TERT promoter, in order to precisely disrupt known cancer-causing mutations in melanomas. He received his B.S. from Elizabethtown College in 2013, where he worked on elucidating the effects of SV40 large Tumor Antigen and p53 on preadipocyte cell differentiation. He earned his M.S. from Drexel University College of Medicine in 2014, where he researched the effects progression of HIV-1 infection has on viral cofactor affinity.